Heart Failure News and Research

RSS
Heart failure (HF) is a condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. It should not be confused with cardiac arrest or myocardial infarction.
FDA extends Novartis' Gleevec label to three-year treatment in patients with KIT+ GIST after surgery

FDA extends Novartis' Gleevec label to three-year treatment in patients with KIT+ GIST after surgery

Leading medical groups collaborate to ensure consistent, responsible uptake of TAVR

Leading medical groups collaborate to ensure consistent, responsible uptake of TAVR

Initial data from Abiomed's Symphony safety trial on chronic heart failure

Initial data from Abiomed's Symphony safety trial on chronic heart failure

Boehringer Ingelheim, Lilly receive FDA approval for Jentadueto to treat type 2 diabetes

Boehringer Ingelheim, Lilly receive FDA approval for Jentadueto to treat type 2 diabetes

ESC welcomes 'intriguing' study on heart failure

ESC welcomes 'intriguing' study on heart failure

Juventas' JVS-100 Phase I heart failure trial meets primary safety endpoint

Juventas' JVS-100 Phase I heart failure trial meets primary safety endpoint

Mayo Clinic Healthy Heart For Life! to be available online on Jan. 31

Mayo Clinic Healthy Heart For Life! to be available online on Jan. 31

Cedars-Sinai Heart Institute to mark National Go Red for Women Day

Cedars-Sinai Heart Institute to mark National Go Red for Women Day

Gilenya prevents and reverses symptoms of ventricular hypertrophy

Gilenya prevents and reverses symptoms of ventricular hypertrophy

AMAG completes enrollment in Feraheme Phase III program for iron-deficiency anemia

AMAG completes enrollment in Feraheme Phase III program for iron-deficiency anemia

Amorcyte commences enrollment in PreSERVE Phase 2 trial for acute myocardial infarction

Amorcyte commences enrollment in PreSERVE Phase 2 trial for acute myocardial infarction

St. Jude Medical fourth quarter net sales increase 4% to $1.407B

St. Jude Medical fourth quarter net sales increase 4% to $1.407B

CHF associated with reduced patency after peripheral endovascular intervention

CHF associated with reduced patency after peripheral endovascular intervention

BioTime obtains license from Wistar Institute for technology related to SP100 gene

BioTime obtains license from Wistar Institute for technology related to SP100 gene

Cytori's ADRCs safe and feasible for patients with AMI

Cytori's ADRCs safe and feasible for patients with AMI

Takeda receives FDA approval for VELCADE sNDA to treat MM

Takeda receives FDA approval for VELCADE sNDA to treat MM

Ikaria receives FDA orphan drug designation for use of iNO in PAH

Ikaria receives FDA orphan drug designation for use of iNO in PAH

Scientists discover finely tuned mechanism associated with CHD

Scientists discover finely tuned mechanism associated with CHD

Sex declared safe for heart patients

Sex declared safe for heart patients

EMA CHMP issues positive opinion to MSD's REMICADE for treatment of pediatric UC

EMA CHMP issues positive opinion to MSD's REMICADE for treatment of pediatric UC

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.